Navigation Links
Intralink-Spine Inc. Awarded $750,000 Small Business Innovation Research Phase II Grant

GEORGETOWN, Texas, Feb. 1 /PRNewswire/ -- Intralink-Spine Inc. (ILS), a privately held medical device company focused on the treatment of degenerative disc disease and low back pain, announced today that it has been awarded a $750,000 Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH) for pre-clinical studies of its NEXT technology.  

Dr. Thomas Hedman, Ph.D., Founder and CSO of ILS, commented: "Securing this grant enables us to complete pre-clinical testing and start First-in-Man clinical trials.  This grant also underscores the mounting enthusiasm for our unique injectable treatment for low back pain, which affects over 15 million people each year in the US alone."

The technology, NEXT (Nonsurgical EXogenous crosslink Therapy), is based on the body's natural response to heal instability and degradation of the spinal disc.  The NEXT device is designed to immediately strengthen and stabilize the disc, reducing disc bulge and pain without the costs and risks associated with surgery.  Dr. Hansen Yuan, M.D., a leader in spine surgery, added: "This injectable tissue reinforcement procedure can provide an effective treatment for patients who are either early in the disease process or adverse to surgery."

About Intralink-Spine Inc.

Intralink-Spine Inc. (ILS) is privately held by Orthopeutics LP (OLP, Georgetown, TX) and a group of angel investors.  OLP is a biotechnology innovator founded in September of 2004 to develop and commercialize revolutionary non-surgical solutions for common orthopaedic problems.  OLP's general partner is Ampac Biotechnology, Inc. also located in Georgetown, TX.  Ampac was founded in 2001 when it was awarded an STTR Phase I grant from the NIH.

For more information on ILS, please visit:

Forward-looking statements

This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting ILS's business including increased competition; the ability of ILS to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.

SOURCE Intralink-Spine Inc.



SOURCE Intralink-Spine Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Palmer Labs Awarded U.S. Department of Energy Funding for Algae Biofuel Research
2. Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software
3. Goble & Associates Creative Work Awarded at Advertising Industry Competitions
4. Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project
5. Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases
6. Blue Marble Energy, OPDA Awarded $2M by WAs Community Economic Revitalization Board
7. Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
8. Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus
9. BioNanomatrix Awarded Supplemental Funding to Accelerate Commercialization of Innovative Single-Molecule Analyzer
10. Novavax Awarded NIH Grant for Respiratory Syncytial Virus (RSV) Vaccine Program
11. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing partnership between ... (OPBAP) has been formalized with the signing of a Memorandum of Understanding. , ... leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential micronutrient ... to proteins, copper is also toxic to cells. With a $1.3 million award ... will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. ...
Breaking Biology Technology:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/17/2015)... , November 17, 2015 Paris ...   --> Paris from 17 th ... DERMALOG, the biometrics innovation leader, has invented the first combined ... on the same scanning surface. Until now two different scanners ... one scanner can capture both on the same surface. ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
Breaking Biology News(10 mins):